This image compares three DNA sequencing technologies: Sanger sequencing, Massively Parallel DNA sequencing, and Nanopore DNA sequencing. Sanger sequencing (left) sequences 500-700 bases per reaction ...
ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17). Characterization of molecular response and progression ...
This is a preview. Log in through your library . Abstract Next-generation sequencing technologies are poised to revolutionize the field of biomedicai research. The increased resolution of these data ...
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab The prognostic model demonstrated ...
In the workflow of AmproCode, each type of the selected residues on peptide or protein samples can be respectively modified by the DNA barcode, and the composition code which is the relative ratio of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results